Search Results - "Koizumi, F"

FGFR2 gene amplification and clinicopathological features in gastric cancer by Matsumoto, K, Arao, T, Hamaguchi, T, Shimada, Y, Kato, K, Oda, I, Taniguchi, H, Koizumi, F, Yanagihara, K, Sasaki, H, Nishio, K, Yamada, Y

“…Background: Frequency of FGFR2 amplification, its clinicopathological features, and the results of high-throughput screening assays in a large cohort of…”
Get full text

Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats by UCHINO, H, MATSUMURA, Y, NEGISHI, T, KOIZUMI, F, HAYASHI, T, HONDA, T, NISHIYAMA, N, KATAOKA, K, NAITO, S, KAKIZOE, T

“…In spite of the clinical usefulness of cisplatin (CDDP), there are many occasions in which it is difficult to continue the administration of CDDP due to its…”
Get full text

Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma by Kondo, S, Ueno, H, Hosoi, H, Hashimoto, J, Morizane, C, Koizumi, F, Tamura, K, Okusaka, T

“…Background: Inflammatory mediators may have decisive roles at different stages of tumour development. Mediators within the pentraxin family may be used as…”
Get full text

Activated PI3K/AKT and MAPK pathways are potential good prognostic markers in node-positive, triple-negative breast cancer by Hashimoto, K., Tsuda, H., Koizumi, F., Shimizu, C., Yonemori, K., Ando, M., Kodaira, M., Yunokawa, M., Fujiwara, Y., Tamura, K.

“…Triple-negative breast cancer (TNBC) patients are a poor prognostic subgroup, and currently, there is no biomarker for targeted therapy. Tissue samples were…”
Get full text

Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA) by KIMURA, H, SUMINOE, M, NAKAO, S, KASAHARA, K, SONE, T, ARAYA, T, TAMORI, S, KOIZUMI, F, NISHIO, K, MIYAMOTO, K, FUJIMURA, M

“…The aim of this study was to evaluate the usefulness of EGFR mutation status in serum DNA as a means of predicting a benefit from gefitinib (IRESSA) therapy in…”
Get full text

FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer by Tamura, K., Shimizu, C., Hojo, T., Akashi-Tanaka, S., Kinoshita, T., Yonemori, K., Kouno, T., Katsumata, N., Ando, M., Aogi, K., Koizumi, F., Nishio, K., Fujiwara, Y.

“…Antibody-dependent-mediated cytotoxicity (ADCC) is one of the modes of action for trastuzumab. Recent data have suggested that fragment C γ receptor (FcγR)…”
Get full text

Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies by Okuma, H S, Koizumi, F, Hirakawa, A, Nakatochi, M, Komori, O, Hashimoto, J, Kodaira, M, Yunokawa, M, Yamamoto, H, Yonemori, K, Shimizu, C, Fujiwara, Y, Tamura, K

“…Background: We aimed to analyse clinical and gene expression profiles to predict pathologic complete response and disease-free survival using two consecutive,…”
Get full text

NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel by Negishi, T, Koizumi, F, Uchino, H, Kuroda, J, Kawaguchi, T, Naito, S, Matsumura, Y

“…NK105 is a micellar nanoparticle formulation designed to enhance the delivery of paclitaxel (PTX) to solid tumours. It has been reported to exert antitumour…”
Get full text

Bismuth glass holey fibers with high nonlinearity by Ebendorff-Heidepriem, Heike, Petropoulos, P, Asimakis, S, Finazzi, V, Moore, R, Frampton, K, Koizumi, F, Richardson, D, Monro, T

“…We report on the progress of bismuth oxide glass holey fibers for nonlinear device applications. The use of micron-scale core diameters has resulted in a very…”
Get full text

Phase 1 study of lenvatinib combined with carboplatin and paclitaxel in patients with non-small-cell lung cancer by Nishio, M, Horai, T, Horiike, A, Nokihara, H, Yamamoto, N, Takahashi, T, Murakami, H, Yamamoto, N, Koizumi, F, Nishio, K, Yusa, W, Koyama, N, Tamura, T

“…Background: This dose-finding study evaluated lenvatinib, an oral multitargeted receptor tyrosine kinase inhibitor, in combination with carboplatin/paclitaxel…”
Get full text

Mutational analysis of primary tumors and single circulating tumor cells captured by a novel dielectrophoretic microwell array system in metastatic breast cancer, oral cancer and lung cancer patients by Sawada, T, Morimoto, A, Akiyama, Y, Suzuki, T, Hosomi, Y, Okuma, Y, Horio, H, Harada, M, Oyama, S, Ogawa, C, Yamashita, T, Maeda, Y, Shimoyama, T, Hishima, T, Koizumi, F

“…An abstract of a study by Sawada et al on the mutational analysis of primary tumors and single circulating tumor cells (CTC) captured by a novel…”
Get full text

Simultaneous determination of dextromethorphan, dextrorphan and doxylamine in human plasma by HPLC coupled to electrospray ionization tandem mass spectrometry: Application to a pharmacokinetic study by Donato, J.L., Koizumi, F., Pereira, A.S., Mendes, G.D., De Nucci, G.

“…► HPLC–ESI-MS method to quantify dextromethorphan, dextrorphan and doxylamine. ► Method was applied in pharmacokinetic study in human plasma. ► Extraction…”
Get full text

303 Combination Effect of Tivantinib with Erlotinib On Cell Proliferation, C-Met Signals and Apoptosis in a Human Non-small Cell Lung Cancer Cell Line by Koizumi, F, Ishii, K, Soga, S, Akinaga, S, Ishida, H, Takahashi, T

Get full text

UP-02.146 Meanings of the Polyunsaturated Fatty Acid in Patients with Prostate Cancer by Yamada, D, Horikawa, Y, Koizumi, F

Get full text

403 A novel dielectrophoretic microwell array system for detection and single cell analysis of circulating tumor cells from breast cancer patients by Sawada, T, Morimoto, A, Mogami, T, Iijima, K, Akiyama, Y, Katayama, K, Futami, T, Yunokawa, M, Tamura, K, Watanabe, M, Koh, Y, Koizumi, F

Get full text

UP-2.129: The Prognosis and Clinical Features of Prostate Cancer Patients with Initial PSA Over 1000ng/ml by Yamada, D, Hirata, T, Koizumi, F, Suyama, B

Get full text

5176 POSTER Gene Expression Profiles Predict Pathological Complete Response to Standard Neoadjuvant Fluorouracil, Doxorubicin, and Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Early Breast Cancer by Tamura, K, Koizumi, F, Shimizu, C, Hojo, T, Akashi-Tanaka, S, Kinoshita, T, Aogi, K, Masuda, N, Yoshida, T, Fujiwara, Y

Get full text

Reference profiling of the genomic response induced by an antimicrotubule agent, TZT-1027 (Soblidotin), in vitro by Shimoyama, T, Hamano, T, Natsume, T, Koizumi, F, Kiura, K, Tanimoto, M, Nishio, K

“…TZT-1027 is an antimicrotubule agent targeting beta-tubulin that is undergoing clinical development. The genomic response of cancer cells to TZT-1027 was…”
Get full text

Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder by Kasahara, Y, Wada, T, Niida, Y, Yachie, A, Seki, H, Ishida, Y, Sakai, T, Koizumi, F, Koizumi, S, Miyawaki, T, Taniguchi, N

“…Fas is an apoptosis-signaling receptor important for homeostasis of the immune system. In this study, Fas-mediated apoptosis and Fas mutations were analyzed in…”
Get full text

Behavior of Pulverized Coal Ash and Physical Property of Dripping Slag under High Pulverized Coal Injection Operation by Ichida, Morimasa, Orimoto, Takashi, Tanaka, Tsuyoshi, Koizumi, Fumio

“…Based on the analysis of tuyere sampling performed in PCR increasing stage of Muroran No. 2 blast furnace of Hokkai Iron & Coke Corporation, examination was…”
Get full text